PATENT CLAIM ANALYSIS

Application Number: 15910708
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["514", "210180"]

Abstract:
The present application provides methods of treating PI3Kδ related disorders using compounds of Formula I: or pharmaceutically acceptable salts thereof.

Claim (Index 40):
The method of  claim 1 , wherein the compound is (S)-4-(3-((R)-1-(4-amino-3-methyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)pyrrolidin-2-one, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 90.0
- Lexical Diversity: 1.04762
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13854789', '14872881', '14193481', '15902742', '15065409']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7819148791709336
- 35 USC 102 Novelty (BERT): 0.6010813251039268
- Combined Prediction Score: 0.763831523764233
- Mean Citation Score: 455.550562
- Max Citation Score: 494.76465
- Similarity Product: 490.2286924045444

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test